definiens: means any and all products in finished form ( and in any formulation, form or dosage strength ) incorporating the Biological Active Subst ance as the sole active ingredient, which are Biosi milar(s ) . A product that would be eligible for review and appro val under the BPCI Act or equivalent EU guidelines as a Biosimilar shall be included in the definition of Product thro ughout the Territory, regardless of whether such product is approved or eligible for approval as a b iosimilar under corresponding Applicable Laws in ea ch country in which it is marketed or sold . Product shall incl ude, where applicable, any formulation, delivery de vice, dispensing device or packaging required for effecti ve use of the Product . For clarity, Products shall exclude biological products incorporating the Biological Ac tive Substance that are not Biosimilars, including Revance ’s product candidates RT001 and RT002 ( such product ca ndidates, the )